Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?

被引：0
|
作者：
Van Brussel, Ilse [1 ]
Van Craenenbroeck, Amaryllis H. [2 ]
Schrijvers, Dorien M. [3 ]
Cools, Nathalie [4 ]
机构：
[1] Univ Antwerp, Lab Pharmacol, B-2610 Antwerp, Belgium
[2] Univ Antwerp Hosp, Div Nephrol Hypertens, B-2650 Antwerp, Belgium
[3] Univ Antwerp, Lab Physiopharmacol, B-2610 Antwerp, Belgium
[4] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2610 Antwerp, Belgium
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2013年 / 2卷 / 02期
关键词：
D O I：
10.3978/j.issn.2223-4683.2012.10.02
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：85 / 88
页数：4
相关论文
共 50 条
  • [21] ROLE OF IMMUNOTHERAPY IN THE TREATMENT OF BLADDER AND RENAL-CELL CARCINOMA
    STONE, NN
    DROLLER, MJ
    SEMINARS IN SURGICAL ONCOLOGY, 1991, 7 (04): : 239 - 243
  • [22] Update on combined immunotherapy for the treatment of advanced renal cell carcinoma
    Gebrael, Georges
    Sahu, Kamal Kant
    Agarwal, Neeraj
    Maughan, Benjamin L. L.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [23] ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinoma
    Roulin, Didier
    Demartines, Nicolas
    Dormond, Olivier
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 492 - 494
  • [24] New therapies in the treatment of renal cell carcinoma
    Levin, M.
    Veliz, M.
    DRUGS OF THE FUTURE, 2007, 32 (06) : 527 - 536
  • [25] New treatment approaches in renal cell carcinoma
    Facchini, Gaetano
    Perri, Francesco
    Caraglia, Michele
    Pisano, Carmela
    Striano, Stefano
    Marra, Luigi
    Fiore, Francesco
    Aprea, Pasquale
    Pignata, Sandro
    Iaffaioli, Rosario Vincenzo
    ANTI-CANCER DRUGS, 2009, 20 (10) : 893 - 900
  • [26] Immunotherapy combinations transform the treatment paradigm for advanced renal cell carcinoma
    Shaya, Justin A.
    McKay, Rana R.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [27] Rational Approaches to Treatment Duration with Immunotherapy in Metastatic Renal Cell Carcinoma
    Singla, Nirmish
    Freifeld, Yuval
    Ghandour, Rashed A.
    Hammers, Hans J.
    EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 31 - 33
  • [28] The timing of immunotherapy and nephrectomy in multimodality treatment of metastatic renal cell carcinoma
    Bex, A
    Horenblas, S
    de Gast, GC
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2003, 2 (03) : 205 - 210
  • [29] DEFINING A NEW PATIENT-FOCUSED TREATMENT APPROACH TO RENAL CELL CARCINOMA (RCC)
    Bellmunt, J.
    Mulders, P.
    Szczylik, C.
    Porta, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 197 - 197
  • [30] Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
    Argentiero, Antonella
    Solimando, Antonio Giovanni
    Krebs, Markus
    Leone, Patrizia
    Susca, Nicola
    Brunetti, Oronzo
    Racanelli, Vito
    Vacca, Angelo
    Silvestris, Nicola
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
12345